德尤比基因酶USP9x调节非小细胞肺癌中林生物合成途径
Tina Becirovic1, Boxi Zhang1, Cecilia Lindskog2
1Department of Physiology and Pharmacology, Solnavägen 9, Biomedicum, Karolinska Institutet, 171 65, Stockholm, Sweden.
Cell death discovery
|July 29, 2024
概括
乌比基特异性酶9X结合 (USP9x) 通过稳定蛋白生物合成,促进非小细胞肺癌 (NSCLC) 的生长. 抑制USP9x会影响瘤的进展,这表明它是肺癌的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 代谢途径 代谢途径
背景情况:
- 代谢重编程对于癌细胞的增殖和瘤的发展至关重要.
- 控制癌症代谢的精确调节机制仍然不完全理解.
研究的目的:
- 确定非小细胞肺癌 (NSCLC) 代谢途径的新型调节剂.
- 为了研究基特异性酶9X连接 (USP9x) 在蛋白生物合成和NSCLC进展中的作用.
主要方法:
- 研究了USP9x和氨酸-5-碳酸盐减少酶3 (PYCR3) 之间的相互作用.
- 在NSCLC细胞系中利用USP9x和PYCR3的淘汰实验.
- 评估了对林生物合成,酸通路和线粒体呼吸的影响.
- 评估了在人类NSCLC组织中的USP9x表达及其对瘤生长 in vitro和 in vivo的影响.
主要成果:
- USP9x被确定为NSCLC中林生物合成的积极调节者.
- USP9x直接稳定PYCR3,这是proline循环中的一个关键酶.
- 破坏USP9x或PYCR3功能减少了林生物合成,影响下游代谢途径.
- 升高的USP9x水平与人类的NSCLC相关,其抑制抑制了瘤生长.
结论:
- USP9x在调节蛋白生物合成方面发挥着关键作用,这是NSCLC生长至关重要的途径.
- USP9x稳定PYCR3代表了一种影响癌症代谢的新机制.
- 抑制USP9x是一种潜在的治疗策略,用于管理NSCLC.
相关概念视频
The Proteasome
822
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
822
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Proteasome Structure
723
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
723
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


